Researchers in the cancer nanomedicine community debate whether use nanoparticles can best deliver drug therapy to tumors passively. Now, new research on human and mouse tumors in mice suggests the question is even more complicated.
Thursday, March 26, 2020
Experiments in mice and human cells shed light on best way to deliver nanoparticle therapy for cancer
Researchers in the cancer nanomedicine community debate whether use nanoparticles can best deliver drug therapy to tumors passively. Now, new research on human and mouse tumors in mice suggests the question is even more complicated.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment